Find XO: Three Billion Launches Genetic Diagnostic SaaS at ACMG (venturesquare.net)

- Three Billion will showcase its genetic variant interpretation SaaS platform, GEBRA, at ACMG 2026 in the United States. - Instead of developing diagnostic equipment, they focus on data interpretation software targeting overseas medical professionals and research institutes. - This approach is noteworthy for startup teams burdened by device development. - However, to move from being introduced at a conference to repeated use by clinicians, accuracy and reliability must be proven in real-world practice.